Pharma Mar (XMAD:PHM) Additional Paid-In Capital : €71.3 Mil(As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Additional Paid-In Capital?

Pharma Mar's quarterly additional paid-in capital stayed the same from Sep. 2023 (€71.3 Mil) to Dec. 2023 (€71.3 Mil) and stayed the same from Dec. 2023 (€71.3 Mil) to Mar. 2024 (€71.3 Mil).

Pharma Mar's annual additional paid-in capital stayed the same from Dec. 2021 (€71.3 Mil) to Dec. 2022 (€71.3 Mil) and stayed the same from Dec. 2022 (€71.3 Mil) to Dec. 2023 (€71.3 Mil).

Pharma Mar Additional Paid-In Capital Historical Data

The historical data trend for Pharma Mar's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Additional Paid-In Capital Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

71.28

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															71.28	71.28	71.28	71.28	71.28

Pharma Mar Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Pharma Mar Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.